Skandinaviska Enskilda Banken AB publ Cuts Stock Holdings in GE HealthCare Technologies Inc. $GEHC

Skandinaviska Enskilda Banken AB publ cut its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 11.1% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 90,129 shares of the company’s stock after selling 11,304 shares during the quarter. Skandinaviska Enskilda Banken AB publ’s holdings in GE HealthCare Technologies were worth $6,766,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently modified their holdings of the company. Empowered Funds LLC lifted its position in shares of GE HealthCare Technologies by 6.1% during the first quarter. Empowered Funds LLC now owns 28,848 shares of the company’s stock worth $2,328,000 after purchasing an additional 1,665 shares during the last quarter. Acadian Asset Management LLC bought a new position in GE HealthCare Technologies during the 1st quarter worth about $259,000. DekaBank Deutsche Girozentrale increased its position in GE HealthCare Technologies by 0.6% during the 2nd quarter. DekaBank Deutsche Girozentrale now owns 54,371 shares of the company’s stock valued at $4,054,000 after purchasing an additional 341 shares during the period. Denali Advisors LLC bought a new stake in shares of GE HealthCare Technologies in the 2nd quarter valued at about $370,000. Finally, Patten Group Inc. lifted its position in shares of GE HealthCare Technologies by 2.7% in the 2nd quarter. Patten Group Inc. now owns 10,416 shares of the company’s stock worth $772,000 after purchasing an additional 271 shares during the period. Institutional investors own 82.06% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently issued reports on GEHC shares. Evercore lifted their price objective on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the company an “outperform” rating in a report on Thursday, February 5th. Jefferies Financial Group lifted their price target on GE HealthCare Technologies from $95.00 to $105.00 and gave the company a “buy” rating in a report on Thursday, December 11th. Stifel Nicolaus upped their price objective on GE HealthCare Technologies from $95.00 to $98.00 and gave the stock a “buy” rating in a research note on Wednesday, February 4th. Piper Sandler boosted their target price on shares of GE HealthCare Technologies from $91.00 to $94.00 and gave the stock an “overweight” rating in a report on Friday, January 30th. Finally, Bank of America raised their price target on shares of GE HealthCare Technologies from $82.00 to $92.00 and gave the company a “neutral” rating in a report on Monday, January 5th. Seven equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $92.50.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $83.01 on Friday. The company has a debt-to-equity ratio of 0.91, a quick ratio of 1.13 and a current ratio of 1.37. The company’s fifty day moving average is $82.26 and its two-hundred day moving average is $77.88. GE HealthCare Technologies Inc. has a one year low of $57.65 and a one year high of $93.14. The firm has a market capitalization of $37.83 billion, a P/E ratio of 18.20, a PEG ratio of 1.83 and a beta of 1.08.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.40 by $0.04. The firm had revenue of $5.70 billion during the quarter, compared to analysts’ expectations of $5.60 billion. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.GE HealthCare Technologies’s revenue was up 7.1% on a year-over-year basis. During the same period in the previous year, the firm posted $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 3rd will be issued a $0.035 dividend. The ex-dividend date is Thursday, April 2nd. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.07%.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.